Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · Real-Time Price · USD

0.2724

-0.0035 (-1.27%)

At close: Apr 4, 2025, 4:00 PM

0.2750

+0.0026 (0.96%)

After-hours: Apr 4, 2025, 7:56 PM EDT

Relmada Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-79.98	-98.79	-157.04	-125.75	-59.46	Upgrade
Depreciation & Amortization	-	-	-	0	0	Upgrade
Loss (Gain) From Sale of Investments	-0.38	0.24	4.81	1.25	0.02	Upgrade
Stock-Based Compensation	30.18	43.81	44.19	40.49	20.78	Upgrade
Other Operating Activities	0	-	-6.35	-	-	Upgrade
Change in Accounts Receivable	-	0.51	-0.51	-	-	Upgrade
Change in Accounts Payable	0.62	-1.76	0.42	2.85	7.82	Upgrade
Change in Other Net Operating Assets	-2.21	4.32	10.68	-10.71	3.03	Upgrade
Operating Cash Flow	-51.76	-51.66	-103.8	-91.87	-27.81	Upgrade
Investment in Securities	51.56	50.45	19.73	-54.12	-34.45	Upgrade
Investing Cash Flow	51.56	50.45	19.73	-54.12	-34.45	Upgrade
Short-Term Debt Repaid	-	-	-	-	-0.11	Upgrade
Total Debt Repaid	-	-	-	-	-0.11	Upgrade
Net Debt Issued (Repaid)	-	-	-	-	-0.11	Upgrade
Issuance of Common Stock	0.25	-	44.7	187.94	28.58	Upgrade
Other Financing Activities	-0.29	-0.1	0.32	-	-	Upgrade
Financing Cash Flow	-0.04	-0.1	45.02	187.94	28.47	Upgrade
Net Cash Flow	-0.23	-1.3	-39.05	41.95	-33.78	Upgrade
Free Cash Flow	-51.76	-51.66	-103.8	-91.87	-27.81	Upgrade
Free Cash Flow Per Share	-1.72	-1.72	-3.50	-5.23	-1.78	Upgrade
Cash Interest Paid	-	-	-	-	0	Upgrade
Levered Free Cash Flow	-54.04	-17.91	-52.34	-46.02	-5.54	Upgrade
Unlevered Free Cash Flow	-54.04	-17.91	-52.34	-46.02	-5.54	Upgrade
Change in Net Working Capital	1.6	-3.09	-4.25	7.95	-10.77	Upgrade

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q